Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT. (Q44301855)

1 December 2017

title

Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT. (English)

1 reference

1 December 2017

Victor J Wroblewski

1 reference

1 December 2017

Derrick R Witcher

1 reference

1 December 2017

Gerald W Becker

1 reference

1 December 2017

Kelly A Davis

1 reference

1 December 2017

Shenshen Dou

1 reference

1 December 2017

Radmila Micanovic

1 reference

1 December 2017

Christy M Newton

1 reference

1 December 2017

Timothy W Noblitt

1 reference

1 December 2017

John M Richardson

1 reference

1 December 2017

Ho Yeong Song

1 reference

1 December 2017

John E Hale

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

1 December 2017

published in

Biochemical Pharmacology

1 reference

1 December 2017

1 reference

1 December 2017

1 reference

1 December 2017

page(s)

657-667

1 reference

Tumor necrosis factor receptor superfamily members and their ligands

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Nerve growth factor is an autocrine survival factor for memory B lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Regulation of apoptosis in the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Modulation of T-cell responses to alloantigens by TR6/DcR3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Immune privilege or inflammation? Insights into the Fas ligand enigma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Therapeutic opportunities from the pharmacological manipulation of the Fas system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Dysregulation of apoptosis as a mechanism of liver disease: an overview.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Identification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: potential regulation of functionality by glycosyltransferase competition for serine474

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

E1a-responsive mammalian host/vector system for the stable high-level expression of secreted proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

FACS-optimized mutants of the green fluorescent protein (GFP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Prolactin proteolysis by glandular kallikrein: in vitro reaction requirements and cleavage sites, and detection of processed prolactin in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Purification and analysis of proteinase-resistant mutants of recombinant platelet-derived growth factor-BB exhibiting improved biological activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Growth Hormone Heterogeneity: Genes, Isohormones, Variants, and Binding Proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Proteolytic cleavage of human growth hormone (hGH) by rat tissues in vitro: influence on the kinetics of exogenously administered hGH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Design and characterisation of long-R3-insulin-like growth factor-I muteins which show resistance to pepsin digestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

Hepatic response to sepsis: interaction between coagulation and inflammatory processes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901612-X

10.1016/S0006-2952(02)01612-X

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference